InsiderClue
← All stocks

Biomea Fusion, Inc.

BMEA Net buying
CIK 0001840439 #4332 in the set updated 22 Sep 2026
Bought (120 mo)
$36.23M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$26.55M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$26.55M
9 of 9 sales
Net
+$9.68M
+$9.68M against sales at will

By person

9 insiders · 31 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chen Bihua
Former Director
$27.30M (2)
—
+$27.30M
6,741,744
$9.66M
+112.6%
A2A Pharmaceuticals, Inc. entity
10% owner
$805.50K (2)
$26.55M (9)
−$25.75M
3,500,000
$5.02M
−11.7%
Erdtmann Rainer M
See Remarks
$3.72M (7)
—
+$3.72M
5,108,369
$7.32M
+5.3%
Butler Thomas Andrew
Chief Executive Officer
$3.62M (4)
—
+$3.62M
4,676,078
$6.70M
+5.1%
Stergiopoulos Sotirios
Director
$379.85K (1)
—
+$379.85K
4,400,000
$6.31M
+0.8%
Hitchcock Michael J.M.
Interim CEO
$239.43K (3)
—
+$239.43K
115,000
$164.83K
—
Valle Franco
Chief Financial Officer
$173.41K (3)
—
+$173.41K
42,995
$61.62K
—
Frias Juan Pablo
Chief Medical Officer
—
—
—
349
$500.22
—
Biomea Health, LLC entity
10% owner
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 36,238,687 to 72,483,852 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
A2A Pharmaceuticals, Inc.
1 Jun 2023
10% owner
Sell
50,000
$34.56
$1.73M
A2A Pharmaceuticals, Inc.
31 May 2023
10% owner
Sell
75,000
$33.81
$2.54M
A2A Pharmaceuticals, Inc.
12 May 2023
10% owner
Sell
25,000
$33.84
$846.00K
A2A Pharmaceuticals, Inc.
9 May 2023
10% owner
Sell
150,000
$34.50
$5.18M
A2A Pharmaceuticals, Inc.
8 May 2023
10% owner
Sell
100,000
$33.99
$3.40M
A2A Pharmaceuticals, Inc.
20 Apr 2023
10% owner
Sell
200,000
$29.12
$5.82M
A2A Pharmaceuticals, Inc.
31 Mar 2023
10% owner
Sell
200,000
$31.25
$6.25M
A2A Pharmaceuticals, Inc.
21 Jul 2022
10% owner
Sell
34,658
$11.21
$388.52K
A2A Pharmaceuticals, Inc.
24 Jun 2022
10% owner
Sell
34,658
$11.76
$407.58K
Show all 31 transactions →

What was left out

Form 4 filings counted 80
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 6,782,949
Sales filed before the plan box existed 2
History held since 19 Apr 2021